Edition:
United States

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

1,338.35INR
28 Apr 2017
Change (% chg)

Rs2.15 (+0.16%)
Prev Close
Rs1,336.20
Open
Rs1,340.00
Day's High
Rs1,372.00
Day's Low
Rs1,318.70
Volume
2,257,402
Avg. Vol
839,001
52-wk High
Rs1,750.00
52-wk Low
Rs1,318.70

LUPN.NS

Chart for LUPN.NS

About

Lupin Limited is a pharmaceutical company. The Company is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world. The Company offers products in the cardiovascular, diabetology, asthma, pediatrics, central... (more)

Overall

Beta: -0.02
Market Cap(Mil.): Rs604,446.31
Shares Outstanding(Mil.): 451.64
Dividend: 7.50
Yield (%): 0.56

Financials

  LUPN.NS Industry Sector
P/E (TTM): 20.71 29.08 30.08
EPS (TTM): 64.61 -- --
ROI: -- 13.73 13.25
ROE: -- 14.68 14.41

BRIEF-Lupin says Goa plant gets three 483 observations by USFDA

* Lupin clarifies on news item, "Lupin's Goa plant receives adverse FDA observations".

Apr 28 2017

BRIEF-Lupin gets FDA approval for hypertension treating drug

* Says Lupin receives FDA approval for generic benicar tablets

Apr 28 2017

Sandoz, Lupin settle Solodyn pay-for-delay cases for $6.7 million

Generic drugmakers Sandoz Inc and Lupin Ltd have agreed to pay $6.72 million to resolve lawsuits accusing them of striking deals with Medicis Pharmaceutical Corp to delay the release of lower-cost versions of acne drug Solodyn.

Apr 05 2017

BRIEF-Lupin launches generic Epzicom tablets in U.S.

* Says drug indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection

Mar 29 2017

BRIEF-Lupin Ltd gets FDA nod for generic Tobi inhalation solution

* Says lupin receives FDA approval for generic Tobi® inhalation solution

Mar 23 2017

BRIEF-Lupin Ltd launches generic Minastrin 24 Fe chewable tablets in U.S.

* Says Lupin launches generic Minastrin 24 Fe chewable tablets in the US

Mar 16 2017

BRIEF-Lupin launches its pain drug in the U.S.

* Says Lupin launches hydrocodone bitartrate and acetaminophen tablets in the U.S.

Mar 08 2017

BRIEF-Lupin launches generic drug to treat major depressive disorder

* Drug indicated to treat major depressive disorder, panic disorder, social anxiety disorder and premenstrual dysphoric disorder Source text: http://bit.ly/2n9awVy Further company coverage:

Mar 07 2017

BRIEF-Lupin announces U.S. launch of generic drug to treat depression

* Says tablets are indicated for the treatment of major depressive disorder Source text: http://bit.ly/2mgR90c Further company coverage:

Mar 02 2017

BRIEF-Lupin launches product for scalp inflammation treatment in the U.S.

* Says Lupin launches generic Temovate® Clobetasol Propionate scalp application in the US

Mar 01 2017

More From Around the Web

Earnings vs. Estimates